Tapentadol is partly metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that greatly enhance or repress the exercise/expression of one or more of those enzymes, and with substrates of those enzymes (on account of Competitiveness for your enzyme); some enzyme mediators/substrates